Revolutions Medical Files an International Patent Application Under PCT for Its New Pre-Filled Auto-Retractable Vacuum Safety Syringe Technology

| Source: Revolutions Medical Corporation

CHARLESTON, S.C., May 3, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) designating all PCT member countries. The patent application is directed to novel proprietary designs for pre-filled and non-pre filled vacuum based retractable syringes. The U.S. provisional patent was filed May 2, 2011 on Revolutions Medical's new pre-filled technology. The new designs improve safety and ease of use, while reducing the cost and complexity of manufacture. The international PCT patent application will strengthen the Company's overall patent coverage related to vacuum safety syringe technology and will allow the Company to address a growing market segment currently experiencing significant attention by pharmaceutical companies.

"While attending the PDA Europe conference in Basel, Switzerland last November, the Company's RevVac™ safety syringe was introduced to the pre-filled market. With the filing of Revolutions Medical's international PCT patent application, the Company can now confidently move ahead to address the needs of this expanding market segment. There are currently almost 50 drugs, including insulin, that are now being delivered in other pre-filled syringes. The Company believes that its new pre-filled vacuum safety syringe designs have a number of advantages over the current competition," stated Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical.

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website:

To be added to the Revolutions Medical investor email list, please email: with RMCP in the subject line.


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Revolutions Medical Corporation
Investor and Corporate Relations
Gregory S. Lowe
Acorn Management Partners
President / Partner